ACADM
acyl-CoA dehydrogenase, C-4 to C-12 straight chain
ACADM; acyl-CoA dehydrogenase, C-4 to C-12 straight chain; acyl Coenzyme A dehydrogenase, C 4 to C 12 straight chain; medium-chain specific acyl-CoA dehydrogenase, mitochondrial; ACAD1; MCAD; MCADH; acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chai;
CLTB
clathrin, light chain B
CLTB; clathrin, light chain B; clathrin, light polypeptide (Lcb); clathrin light chain B; Lcb; clathrin, light chain (Lcb);
COX4NB
COX4 neighbor
COX4NB; COX4 neighbor; C16orf2, C16orf4, chromosome 16 open reading frame 2 , chromosome 16 open reading frame 4 , neighbor of COX4 , NOC4; neighbor of COX4; FAM158B; family with sequence similarity 158; member B; C16orf4; COX4AL; CX4NB_HUMAN; NOC4; Protein FAM158B; OTTHUMP00000175002; family with sequence similarity 158, member B; C16orf2;
DNAL4
dynein, axonemal, light chain 4
DNAL4; dynein, axonemal, light chain 4; dynein, axonemal, light 4 , dynein, axonemal, light polypeptide 4; dynein light chain 4, axonemal; dJ327J16; PIG27; dynein, axonemal, light 4; proliferation-inducing gene 27; dynein light chain, outer arm 4; prolif;
DYNLL1
dynein, light chain, LC8-type 1
DYNLL1; dynein, light chain, LC8-type 1; DNCL1, dynein, cytoplasmic, light polypeptide 1; dynein light chain 1, cytoplasmic; DLC1; DLC8; hdlc1; LC8; PIN; 8 kDa dynein light chain; cytoplasmic dynein light polypeptide; dynein, cytoplasmic, light polypepti;
DYNLRB2
dynein, light chain, roadblock-type 2
DYNLRB2; dynein, light chain, roadblock-type 2; DNCL2B, dynein, cytoplasmic, light polypeptide 2B; dynein light chain roadblock-type 2; DNLC2B; roadblock domain containing 2; ROBLD2; bithoraxoid-like protein; dynein light chain 2B, cytoplasmic; roadblock;
Fcgr1
Fc receptor, IgG, high affinity I
FCGR1;Fc receptor, IgG, high affinity I;high affinity immunoglobulin gamma Fc receptor I;fcRI;fc-gamma RI;igG Fc receptor I;IgG high affinity Fc receptor;CD64;IGGHAFC;AI323638;AV092959;FcgammaRI;
FCGR1A
Fc fragment of IgG, high affinity Ia, receptor (CD64)
FCGR1A; Fc fragment of IgG, high affinity Ia, receptor (CD64); high affinity immunoglobulin gamma Fc receptor I; Fc receptor, IgG, high affinity I; high affinity IgG Fc receptor, subunit beta; Fc fragment of IgG high affinity Ib receptor; high-affinity immunoglobulin gamma Fc receptor I; Fc fragment of IgG, high affinity Ib, receptor for (CD64); Fcgr1; Fcgr1b; FcgammaRI;
FTL
ferritin, light polypeptide
FTL; ferritin, light polypeptide; LFTD; NBIA3; ferritin light chain; ferritin L-chain; ferritin L subunit; ferritin light polypeptide-like 3;
GH1
growth hormone 1
gH; GH-N; GH1; GHN; Growth hormone 1; Growth hormone; Growth hormone, normal; Growth hormone, pituitary; HG1; hGH-N; IGHD1B; Pituitary growth hormone; RNGHGP; SOMA_HUMAN; Somatotropin;
GHRH
Ghrh growth hormone releasing hormone
GHRH; growth hormone releasing hormone; somatoliberin; GRF; growth hormone-releasing factor; growth hormone-releasing hormone; GHRF;
GHRL
Ghrelin/Obestatin Prepropeptide
Ghrelin/obestatin prepropeptide; obestatin; ghrelin,growth hormone secretagogue receptor ligand; Growth hormone-releasing peptide; appetite-regulating hormone; Motilin related peptide; ghrelin/obestatin preprohormone; Growth hormone secretagogue; proteinM46; ghrelin; MTLRP; OTTHUMP00000207791; OTTHUMP00000207792; OTTHUMP00000207790; OTTHUMP00000207793; OTTHUMP00000207794; OTTHUMP00000207795; OTTHUMP00000207796; OTTHUMP00000207797; OTTHUMP00000207798; OTTHUMP00000226986; GHRL;
HMGB1
high mobility group box 1
HMGB1; high mobility group box 1; high mobility group (nonhistone chromosomal) protein 1 , high mobility group box 1 , HMG1; high mobility group protein B1; Amphoterin; DKFZp686A04236; high mobility group protein 1; HMG3; SBP 1; Sulfoglucuronyl carbohydrate binding protein; HMG-1; high-mobility group box 1; high-mobility group (nonhistone chromosomal) protein 1; HMG1; SBP-1;
HMGN1
high mobility group nucleosome binding domain 1
HMGN1; high mobility group nucleosome binding domain 1; high mobility group (nonhistone chromosomal) protein 14 , high mobility group nucleosome binding domain 1 , HMG14; non-histone chromosomal protein HMG-14; FLJ27265; FLJ31471; high mobility group nuc;
IKBKB
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
IKBKB; IKK2; IKKB; NFKBIKB; FLJ33771; FLJ36218; FLJ38368; FLJ40509; IKK-beta; MGC131801; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta; inhibitor of nuclear factor kappa-B kinase subunit beta; IKK-B; I-kappa-B kinase 2; OTTHUMP00000225854; OTTHUMP00000225858; OTTHUMP00000225860; OTTHUMP00000225865; OTTHUMP00000225866; I-kappa-B-kinase beta; nuclear factor NF-kappa-B inhibitor kinase beta;
IKBKE
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
IKBKE; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon; inhibitor of nuclear factor kappa-B kinase subunit epsilon; IKK i; IKKE; KIAA0151; IKK-epsilon; I-kappa-B kinase epsilon; inducible IkappaB kinase; IKK-related kinase epsilon; inducible I kappa-B kinase; IKKI; IKK-E; IKK-i; MGC125294; MGC125295; MGC125297;
LEFTY1
left-right determination factor 1
LEFTY1; left-right determination factor 1; LEFTB; LEFTYB; protein lefty-1; protein lefty-B; left-right determination factor B; left-right determination, factor B;
LEFTY2
left-right determination factor 2
LEFTY2; left-right determination factor 2; EBAF, endometrial bleeding associated factor (left right determination, factor A; transforming growth factor beta superfamily) , TGFB4; LEFTA; LEFTYA; transforming growth factor; beta 4 (endometrial bleeding associated factor; LEFTY A); EBAF; Endometrial bleeding associated factor (left right determination factor A transforming growth factor beta superfamily); Endometrial bleeding associated factor; Endometrial bleeding-associated factor; LEFTY 2; TGF-beta-4; protein lefty-2; protein lefty-A; left-right determination factor A; transforming growth factor beta-4; TGFB4;
MAP1LC3A
microtubule-associated protein 1 light chain 3 alpha
MAP1LC3A; microtubule-associated protein 1 light chain 3 alpha; ATG8E; LC3; LC3A; MAP1ALC3; MAP1BLC3;
MAP1LC3B
microtubule-associated protein 1 light chain 3 beta
MAP1LC3B; microtubule-associated protein 1 light chain 3 beta; microtubule-associated proteins 1A/1B light chain 3B; ATG8F; MAP1A/MAP1B LC3 B; MAP1A/MAP1B light chain 3 B; MAP1 light chain 3-like protein 2; autophagy-related ubiquitin-like modifier LC3 B; LC3B; MAP1LC3B-a; MAP1A/1BLC3;
MYL12B
myosin, light chain 12B, regulatory
MLC-B; MRLC2; myosin regulatory light chain 12B; MLC-2; MLC20; MLC-2A; SHUJUN-1; OTTHUMP00000162244; OTTHUMP00000165806; OTTHUMP00000165807; OTTHUMP00000165808; myosin regulatory light chain 2; myosin regulatory light chain MRLC2; myosin regulatory light chain 20 kDa; myosin regulatory light chain 2-B, smooth muscle isoform; MYL12B; myosin, light chain 12B, regulatory;
MYL6
myosin, light chain 6, alkali, smooth muscle and non-muscle
MYL6; myosin, light chain 6, alkali, smooth muscle and non-muscle; myosin, light polypeptide 6, alkali, smooth muscle and non muscle; myosin light polypeptide 6; ESMLC; MLC1SM; MLC3NM; myosin light chain A3; 17 kDa myosin light chain; myosin light chain a;
MYL9
myosin, light chain 9, regulatory
MYL9; myosin, light chain 9, regulatory; myosin, light polypeptide 9, regulatory; myosin regulatory light polypeptide 9; LC20; MLC2; MRLC1; myosin regulatory light chain 1; myosin regulatory light chain 2; smooth muscle isoform; MYRL2; myosin RLC; 20 kDa myosin light chain; myosin regulatory light chain 9; myosin regulatory light chain MRLC1; myosin regulatory light chain 2, smooth muscle isoform; MLC-2C; MGC3505;
MYLK
myosin light chain kinase
MYLK; myosin light chain kinase; myosin, light polypeptide kinase; myosin light chain kinase, smooth muscle; MLCK; MLCK1; MYLK1; smMLCK; smooth muscle myosin light chain kinase; telokin; kinase-related protein; KRP; AAT7; MLCK108; MLCK210; MSTP083; FLJ122;
MYLK2
myosin light chain kinase 2
MYLK2; myosin light chain kinase 2; myosin light chain kinase 2, skeletal muscle; myosin light chain kinase 2, skeletal/cardiac muscle; KMLC; MLCK2; skeletal muscle myosin light chain kinase; skMLCK; MLCK;
MYLK3
myosin light chain kinase 3
MYLK3; myosin light chain kinase 3; putative myosin light chain kinase 3; caMLCK; MLC kinase; MLCK; cardiac-MyBP-C associated Ca/CaM kinase; cardiac-MyBP-C-associated Ca/CaM kinase; MLCK2; MGC126319; MGC126320;
MYLPF
myosin light chain, phosphorylatable, fast skeletal muscle
MYLPF; myosin light chain, phosphorylatable, fast skeletal muscle; myosin regulatory light chain 2, skeletal muscle isoform; MLC2F; myosin light chain 2; fast skeletal myosin light chain 2; Mlc2; MLC-2; 2410014J02Rik;
NFKB1
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
NFKB1; p50; KBF1; p105; EBP-1; MGC54151; NFKB-p50; NFkappaB; NF-kappaB; NFKB-p105; DKFZp686C01211; nuclearfactor NF-kappa-Bp105subunit; NF-kappabeta; OTTHUMP00000161765; OTTHUMP00000216418; OTTHUMP00000219572; DNA binding factor KBF1; nuclear factor NF-kappa-B p50 subunit; nuclear factor kappa-B DNA binding subunit;
NFKBIA
nuclear factor of kappa light polypeptide gene enhancer in B-cell extracts inhibitor, alpha
IKBA; MAD-3; NFKBI; I-kappa-B-alpha; IkappaBalpha; NF-kappa-B inhibitor alpha; ikB-alpha; major histocompatibility complex enhancer-binding protein MAD3; nuclear factor of kappa light chain gene enhancer in B-cells;
TFE3
transcription factor binding to IGHM enhancer 3
TFE3; transcription factor binding to IGHM enhancer 3; TFEA; RCCP2; RCCX1; bHLHe33; transcription factor E3; transcription factor for IgH enhancer; transcription factor E family, member A; class E basic helix-loop-helix protein 33; transcription factor for immunoglobulin heavy-chain enhancer 3;
TJP1
tight junction protein 1 (zona occludens 1)
TJP1; tight junction protein 1 (zona occludens 1); tight junction protein ZO-1; DKFZp686M05161; MGC133289; tight junction protein ZO 1; ZO 1; zona occludens 1; zona occludens protein 1; zonula occludens 1 protein; zonula occludens protein 1; ZO-1;
MYL12A
myosin, light chain 12A, regulatory, non-sarcomeric
MYL12A; myosin, light chain 12A, regulatory, non-sarcomeric; myosin, light polypeptide, regulatory, non sarcomeric (20kD); myosin regulatory light chain 12A; MLCB; MRCL3; MRLC3; MYL2B; myosin regulatory light chain 3; nonsarcomeric; RLC; ML12A_HUMAN; MLC 2B; MLC-2B; Myosin regulatory light chain 2; Myosin regulatory light chain 2, nonsarcomeric; Myosin regulatory light chain MRCL3; Myosin regulatory light chain MRLC3; Myosin RLC; OTTHUMP00000162243; myosin, light polypeptide, regula;
MYL7
myosin, light chain 7, regulatory
MYL7; myosin, light chain 7, regulatory; myosin, light polypeptide 7, regulatory; myosin regulatory light chain 2, atrial isoform; MYL2A; MYLC2A; atrial isoform; MLC-2a; MLC2a; MLRA_HUMAN; Myosin light chain 2a; Myosin regulatory light chain 2; Myosin regulatory light chain 7;
NFKB2
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
NFKB2; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100); nuclear factor NF-kappa-B p100 subunit; LYT 10; NF kB2; p52; p105; oncogene Lyt-10; DNA-binding factor KBF2; lymphocyte translocation chromosome 10 protein; nuclear fa;
NFKBIB
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
NFKBIB; IKBB; TRIP9; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta; NF-kappa-B inhibitor beta; ikB-B; TRIP-9; ikB-beta; ikappaBbeta; NF-kappa-BIB; I-kappa-B-beta; TR-interacting protein 9; thyroid receptor-interacting protein 9;
NFKBIE
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon
NFKBIE; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon; NF-kappa-B inhibitor epsilon; IKBE; ikB-E; ikB-epsilon; NF-kappa-BIE; ikappaBepsilon; I-kappa-B-epsilon;
MYL3
myosin, light chain 3, alkali; ventricular, skeletal, slow
MYL3; myosin, light chain 3, alkali; ventricular, skeletal, slow; myosin, light polypeptide 3, alkali; ventricular, skeletal, slow; myosin light chain 3; CMH8; MLC1SB; MLC1V; VLC1; CMLC1; cardiac myosin light chain 1; ventricular/slow twitch myosin alkali;
HMGA1
high mobility group AT-hook 1
HMGA1; high mobility group AT-hook 1; high mobility group (nonhistone chromosomal) protein isoforms I and Y , HMGIY; high mobility group protein HMG-I/HMG-Y; HMG-I(Y); high mobility group protein R; high mobility group protein A1; nonhistone chromosomal h;
HMGB2
high mobility group box 2
HMGB2; high mobility group box 2; high mobility group (nonhistone chromosomal) protein 2 , high mobility group box 2 , HMG2; high mobility group protein B2; HMG-2; high-mobility group box 2; high mobility group protein 2; high-mobility group (nonhistone;
ARID3A
AT rich interactive domain 3A (BRIGHT-like)
ARID3A; AT rich interactive domain 3A (BRIGHT-like); AT rich interactive domain 3A (BRIGHT like) , dead ringer like 1 (Drosophila) , DRIL1; AT-rich interactive domain-containing protein 3A; BRIGHT; dead ringer-like 1; E2F-binding protein 1; ARID domain-;
FCER1A
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
FCER1A; Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide; FCE1A; high affinity immunoglobulin epsilon receptor subunit alpha; Fc-epsilon RI-alpha; Fc epsilon RI alpha-chain; igE Fc receptor subunit alpha; Fc IgE receptor, alpha polypep;
HMGA2
high mobility group AT-hook 2
HMGA2; high mobility group AT-hook 2; high mobility group (nonhistone chromosomal) protein isoform I C , HMGIC; high mobility group protein HMGI-C; BABL; LIPO; High-mobility group protein HMGI-C; high mobility group AT-hook protein 2; high-mobility group;
HMGB3
high mobility group box 3
HMGB3; high mobility group box 3; high mobility group (nonhistone chromosomal) protein 4 , high mobility group box 3 , HMG4; high mobility group protein B3; HMG2A; MGC90319; non histone chromosomal protein; High mobility group protein 2a; High mobility group protein HMG4; HMG 4; HMGB 3; Nonhistone chromosomal protein HMG4; high-mobility group box 3; high mobility group protein 4; non-histone chromosomal protein; high-mobility group (nonhistone chromosomal) protein 4; HMG4; HMG-4; HMG-2a;
IKBKAP
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein; IKBKAP; FD; DYS; ELP1; IKAP; IKI3; TOT1; FLJ12497; DKFZp781H1425; elongator complex protein 1; p150; OTTHUMP00000021869; IKK complex-associated protein; ikappaB kinase complex-associated protein;
IKBKG
IKBKG inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
IKBKG; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; incontinentia pigmenti , IP1, IP2; NF-kappa-B essential modulator; FIP 3; FIP3; Fip3p; IKK gamma; NEMO; IKKG; IKKAP1; incontinentia pigmenti; IkB kinase gamma subunit; ikB kinase subunit gamma; NFkappaB essential modulator; NF-kappa-B essential modifier; I-kappa-B kinase subunit gamma; ikB kinase-associated protein 1; inhibitor of nuclear factor kappa-B kinase subunit gamma; IP; IP1; IP2; IPD2; FIP-3; AMCBX1; IKK-gamma;
MYL1
myosin, light chain 1, alkali; skeletal, fast
MYL1; myosin, light chain 1, alkali; skeletal, fast; myosin, light polypeptide 1, alkali; myosin light chain 1/3, skeletal muscle isoform; MLC1/MLC3; MLC1F/MLC3F; A1 catalytic; A2 catalytic; myosin light chain A1/A2; myosin light chain alk;
MYL4
myosin, light chain 4, alkali; atrial, embryonic
MYL4; myosin, light chain 4, alkali; atrial, embryonic; myosin, light polypeptide 4, alkali; myosin light chain 4; ALC1; AMLC; GT1; myosin; atrial/fetal muscle; light chain; PRO1957; embryonic muscle/atrial isoform; ALC 1; Atrial/embryonic alkali myosin light chain; GT 1; MLC 1; MLC1; MYL 4; MYL4_HUMAN; Myosin atrial/fetal muscle light chain; Myosin light chain 1; Myosin light chain 1 embryonic muscle/atrial isoform; Myosin light chain 4 alkali atrial embryonic; Myosin light chain alkali GT 1 isoform; Myosin light chain alkali GT-1 isoform; Myosin light polypeptide 4 alkali atrial embryonic; Myosin light polypeptide 4; myosin, atrial/fetal muscle, light chain; myosin light chain 1, embryonic muscle/atrial isoform;
MYL5
myosin, light chain 5, regulatory
MYL5; myosin, light chain 5, regulatory; myosin, light polypeptide 5, regulatory; myosin light chain 5; MYL 5; MYL5_HUMAN; MyLC 2; MyLC-2; MYLC2; Myosin light chain 5 regulatory; Myosin light polypeptide 5; Myosin light polypeptide 5 regulatory; Myosin regulatory light chain 5; Superfast myosin regulatory light chain 2; OTTHUMP00000217187; OTTHUMP00000217188; OTTHUMP00000217190; OTTHUMP00000217193;
MYL6B
myosin, light chain 6B, alkali, smooth muscle and non-muscle
MYL6B; myosin, light chain 6B, alkali, smooth muscle and non-muscle; myosin, light polypeptide 6B, alkali, smooth muscle and non muscle; myosin light chain 6B; MLC1SA; myosin light chain 1 slow a; MYL 6B; MYL6B_HUMAN; Myosin alkali light chain 1 slow a; Myosin light chain 1 slow twitch muscle A isoform; Myosin light chain 1 slow-twitch muscle A isoform; Myosin light chain 6B alkali smooth muscle and non muscle; Myosin light polypeptide 6B alkali smooth muscle and non muscle; Myosin light polypeptide 6B; Smooth muscle and non muscle myosin alkali light chain 6B; Smooth muscle and nonmuscle myosin light chain alkali 6B; OTTHUMP00000243208; OTTHUMP00000243210; OTTHUMP00000243299; myosin light chain 1, slow-twitch muscle A isoform; smooth muscl;
NBR1
neighbor of BRCA1 gene 1
NBR1; neighbor of BRCA1 gene 1; M17S2, membrane component, chromosome 17, surface marker 2 (ovarian carcinoma antigen CA125); next to BRCA1 gene 1 protein; 1A1 3B; CA125; KIAA0049; protein 1A1-3B; migration-inducing protein 19; neighbor of BRCA1 gene 1 p;
NEFL
neurofilament, light polypeptide
NEFL; neurofilament, light polypeptide; neurofilament, light polypeptide 68kDa; neurofilament light polypeptide; CMT1F; CMT2E; NF68; NFL; neurofilament subunit NF-L; neurofilament triplet L protein; neurofilament protein, light chain; light molecular weig;
SLC1A2
solute carrier family 1 (glial high affinity glutamate transporter), member 2
SLC1A2; solute carrier family 1 (glial high affinity glutamate transporter), member 2; EAAT2; GLT-1; excitatory amino acid transporter 2; glutamate/aspartate transporter II; excitotoxic amino acid transporter 2; sodium-dependent glutamate/aspartate transporter 2;
STON1-GTF2A1L
STON1-GTF2A1L readthrough
STON1-GTF2A1L; STON1-GTF2A1L readthrough; STON1-GTF2A1L protein; SALF; stoned B/TFIIA alpha/beta like factor; SBLF; STN 1; Stoned B like factor; Stonin 1; OTTHUMP00000159452; OTTHUMP00000200508; OTTHUMP00000201180; stoned B/TFIIA-alpha/beta-like factor;
DYNC1LI1
dynein, cytoplasmic 1, light intermediate chain 1
DYNC1LI1; dynein, cytoplasmic 1, light intermediate chain 1; DNCLI1, dynein, cytoplasmic, light intermediate polypeptide 1; cytoplasmic dynein 1 light intermediate chain 1; DLC-A; dynein light chain A; dynein light chain-A; dynein light intermediate chai;
SLC7A8
solute carrier family 7 (amino acid transporter light chain, L system), member 8
SLC7A8; solute carrier family 7 (amino acid transporter light chain, L system), member 8; LAT2; LPI-PC1; large neutral amino acids transporter small subunit 2; integral membrane protein E16H; L-type amino acid transporter 2; solute carrier family 7 (amino acid transporter, L-type), member 8; solute carrier family 7 (cationic amino acid transporter, y+ system), member 8;
NFKBIZ
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
NFKBIZ; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta; NF-kappa-B inhibitor zeta; FLJ34463; MAIL; ikB-zeta; ikappaBzeta; IkappaB-zeta; I-kappa-B-zeta; Ikappa B-zeta variant 3; IL-1 inducible nuclear ankyrin-repeat prot;
DYNLL2
dynein, light chain, LC8-type 2
DYNLL2; dynein, light chain, LC8-type 2; dynein light chain 2, cytoplasmic; C87222; cytoplasmic; DNCL1B; MGC17810; 8 kDa dynein light chain b; Dlc2; DLC8b; DYL2_HUMAN; Dynein light chain 2; Dynein light chain LC8 type 2; Dynein light chain LC8-type 2; MGC72334; radial spoke 22 homolog; RSPH22;
CLTA
clathrin, light chain A
CLTA;clathrin, light chain A;clathrin, light polypeptide (Lca);clathrin light chain A;Lca;LCA;
DNALI1
dynein, axonemal, light intermediate chain 1
DNALI1; dynein, axonemal, light intermediate chain 1; dynein, axonemal, light intermediate polypeptide 1; axonemal dynein light intermediate polypeptide 1; dJ423B22.5; dJ423B22.5 (axonemal dynein light chain (hp28)); hp28; inner dynein arm; homolog of clamydomonas; P28; Axonemal dynein light chain (hp28); Axonemal dynein light chain; DNALI 1; Dynein axonemal light intermediate chain 1; Dynein axonemal light intermediate polypeptide 1; Inner dynein arm homolog of clamydomonas; Inner dynein arm light chain axonemal; OTTHUMP00000004400; inner dynein arm light chain, axonemal; inner dynein arm, homolog of clamydomonas;
HMG20A
high mobility group 20A
HMG20A; high mobility group 20A; high mobility group protein 20A; FLJ10739; HMG box domain containing 1; HMGX1; HMGXB1; high-mobility group 20A; HMG box-containing protein 20A; HMG domain-containing protein 1; HMG domain-containing protein HMGX1;
HMG20B
high mobility group 20B
HMG20B; high mobility group 20B; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related; BRAF25; BRAF35; HMG box domain containing 2; HMGX2; HMGXB2; SMARCE1r; SOXL; SMARCE1-related protein; high-mobility grou;
HMGN3
high mobility group nucleosomal binding domain 3
HMGN3; high mobility group nucleosomal binding domain 3; thyroid hormone receptor interactor 7 , TRIP7; high mobility group nucleosome-binding domain-containing protein 3; DKFZp686E20226; FLJ42187; HMGN3_HUMAN; OTTHUMP00000016772; OTTHUMP00000016773; PNAS 24; PNAS 25; PNAS24; PNAS25; Thyroid hormone receptor interacting protein 7; Thyroid receptor-interacting protein 7; TR-interacting protein 7; TRIP 7; TRIP-7; TRIP7; PNAS-24; PNAS-25;
JMJD7-PLA2G4B
JMJD7-PLA2G4B readthrough
JMJD7-PLA2G4B;JMJD7-PLA2G4B readthrough;JMJD7-PLA2G4B protein;jumonji domain containing 7-phospholipase A2, group IVB (cytosolic) read-through;HsT16992;cPLA2-beta;
MYLIP
myosin regulatory light chain interacting protein
MYLIP; myosin regulatory light chain interacting protein; E3 ubiquitin-protein ligase MYLIP; E3 ubiquitin ligase inducible degrader of the low density lipoprotein receptor; IDOL; MIR; band 4.1 superfamily member BZF1; inducible degrader of the LDL-recepto;
SLC1A3
solute carrier family 1 (glial high affinity glutamate transporter), member 3
SLC1A3; solute carrier family 1 (glial high affinity glutamate transporter), member 3; excitatory amino acid transporter 1; glutamate/aspartate transporter; solute carrier family 1 member 3; solute carrier family 1, member 3; glial high affinity glutamate transporter; high-affinity neuronal glutamate transporter; sodium-dependent glutamate/aspartate transporter 1; Gmt1; Eaat1; GLAST; GLU-T; GluT-1; MGluT1; GLAST-1; AI504299; B430115D02Rik;
SLC7A5
solute carrier family 7 (amino acid transporter light chain, L system), member 5
SLC7A5; solute carrier family 7 (amino acid transporter light chain, L system), member 5; large neutral amino acids transporter small subunit 1; CD98; D16S469E; E16; LAT1; MPE16; 4F2 LC; 4F2 light chain; CD98 light chain; integral membrane protein E16; L-;
SLC7A7
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7
SLC7A7; solute carrier family 7 (amino acid transporter light chain, y+L system), member 7; LPI; Y+L amino acid transporter 1; y+LAT 1; monocyte amino acid permease 2; y(+)L-type amino acid transporter 1; solute carrier family 7 (cationic amino acid trans;
HDLBP
high density lipoprotein binding protein
HDLBP; high density lipoprotein binding protein; HBP; VGL; PRO2900; vigilin; HDL-binding protein; high density lipoprotein-binding protein;
Tox
thymocyte selection-associated high mobility group box
TOX; thymocyte selection-associated high mobility group box; thymocyte selection-associated high mobility group box protein TOX; KIAA0808; TOX1; Thymus high mobility group box protein TOX; TOX 1;
SLC1A6
Slc1a6 solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6
SLC1A6; solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6; excitatory amino acid transporter 4; solute carrier family 1 member 6; solute carrier family 1, member 6; high-affinity neuronal glutamate transporter; sodium-dependent glutamate/aspartate transporter; EAAT4;
FLII
flightless I homolog
FLII; flightless I homolog (Drosophila); flightless I (Drosophila) homolog; protein flightless-1 homolog; FLI; Fli1; FLIL; MGC39265;
KLC1
kinesin light chain 1
KLC1; kinesin light chain 1; Kinesin 2 60/70kDa; Kinesin2; KLC 1; KLC; KLC1_HUMAN; KNS 2; KNS 2A; KNS2; KNS2A; Medulloblastoma antigen MU MB 2.50; MGC15245; kinesin 2;
MEF2BNB-MEF2B
MEF2BNB-MEF2B readthrough
MEF2BNB-MEF2B; MEF2BNB-MEF2B readthrough; myocyte enhancer factor 2B; PRDM3; MADS box transcription enhancer factor 2; MDS1 EVI1; Mef2b; MEF2B_HUMAN; Myocyte specific enhancer factor 2B; Myocyte-specific enhancer factor 2B; RSRFR2; Serum response factor like protein 2; Serum response factor-like protein 2; XMEF2; LOC729991-MEF2B readthrough; LOC729991-MEF2B;
NTSR1
neurotensin receptor 1 (high affinity)
NTSR1; neurotensin receptor 1 (high affinity); neurotensin receptor type 1; NTR; High affinity levocabastine insensitive neurotensin receptor; NT R 1; NTR1; NTRH; NTRR; NTSR 1; NT-R-1; OTTHUMP00000031500; high-affinity levocabastine-insensitive neurotensin receptor;
SLC1A1
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
SLC1A1; solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1; excitatory amino acid transporter 3; EAAC1; EAAT3; excitatory amino acid carrier 1; solute carrier family 1 member 1; neuronal and epithelial;
SLC7A11
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11
SLC7A11; solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11; xCT; CCBR1; cystine/glutamate transporter; amino acid transport system xc-; solute carrier family 7 member 11; calcium channel blocker resistance protein CCBR1; solute carrier family 7, (cationic amino acid transporter, y+ system) member 11;
C8orf44-SGK3
C8orf44-SGK3 readthrough
C8ORF44-SGK3;C8orf44-SGK3 readthrough;serine/threonine-protein kinase Sgk3;cytokine-independent survival kinase;serum/glucocorticoid-regulated kinase 3;DKFZp779G0825;
KLRC4-KLRK1
KLRC4-KLRK1 readthrough
KLRC4-KLRK1;KLRC4-KLRK1 readthrough;NKG2-D type II integral membrane protein;NK cell receptor D;NKG2-D-activating NK receptor;killer cell lectin-like receptor subfamily K member 1;FLJ17759;FLJ78582;
LOC100009542
myosin light chain 2 type 2
MYLPF; myosin regulatory light chain 2, skeletal muscle isoform type 2;
Tox4
TOX high mobility group box family member 4
TOX4; TOX high mobility group box family member 4; C14orf92, chromosome 14 open reading frame 92 , KIAA0737; LCP1; migration-inducing protein 7; epidermal Langerhans cell protein LCP1; MIG7; C14orf92; KIAA0737;
ARID3C
AT rich interactive domain 3C (BRIGHT-like)
ARID3C; AT rich interactive domain 3C (BRIGHT-like); AT rich interactive domain 3C (BRIGHT like); AT-rich interactive domain-containing protein 3C; AT rich interactive domain containing protein 3C; ARID domain containing protein 3C; ARID domain-containing protein 3C;
AXDND1
axonemal dynein light chain domain containing 1
AXDND1; axonemal dynein light chain domain containing 1; C1orf125, chromosome 1 open reading frame 125; axonemal dynein light chain domain-containing protein 1; FLJ32940; FLJ25438; C1orf125; CA125_HUMAN; DKFZp686H1423; hypothetical protein LOC126859; RP11-215I23.2; Uncharacterized protein C1orf125;
ARID3B
AT rich interactive domain 3B (BRIGHT-like)
ARID3B; AT rich interactive domain 3B (BRIGHT-like); AT rich interactive domain 3B (BRIGHT like); AT-rich interactive domain-containing protein 3B; BDP; DRIL2; bright-like protein; bright and dead ringer protein; ARID domain-containing protein 3B; AT ric;
TOX2
TOX high mobility group box family member 2
TOX2; TOX high mobility group box family member 2; C20orf100, chromosome 20 open reading frame 100; dJ1108D11.2; GCX 1; granulosa cell HMG box 1; Chromosome 20 open reading frame 100; dJ495O3.1; GCX1; Granulosa cell HMG box protein 1; MGC15880; Weakly similar to NONHISTONE CHROMOSOMAL PROTEIN 6A [S.cerevisiae]; OTTHUMP00000031037; OTTHUMP00000031038; GCX-1; C20orf100;
FCER1G
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide
FCER1G; Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide; high affinity immunoglobulin epsilon receptor subunit gamma; fcRgamma; fceRI gamma; fc-epsilon RI-gamma; Fc receptor gamma-chain; immunoglobulin E receptor, high affinity, gamma;
GGH
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
GGH; gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase); gamma-glutamyl hydrolase; gamma-Glu-X carboxypeptidase; GH;
GGTLC2
gamma-glutamyltransferase light chain 2
GGTLC2; gamma-glutamyltransferase light chain 2; gamma glutamyltransferase like 4 , GGTL4; Gamma-glutamyltransferase-like protein 4; GGTL2_HUMAN; GGTL4; gamma-glutamyltransferase-like 4;
GHDC
GH3 domain containing
GHDC; GH3 domain containing; GH3 domain-containing protein; LGP1; D11LGP1; D11LGP1E; D11lgp1e like; GH3 domain containing protein; Homolog of mouse LGP1;
HMGN4
high mobility group nucleosomal binding domain 4
HMGN4; high mobility group nucleosomal binding domain 4; high mobility group (nonhistone chromosomal) protein 17 like 3 , HMG17L3; high mobility group nucleosome-binding domain-containing protein 4; NHC; High mobility group (nonhistone chromosomal) protein 17 like 3; High mobility group protein 17 like 3; High mobility group protein N4; HMG17L3; HMGN4_HUMAN; MGC5145; Non-histone chromosomal protein; Non-histone chromosomal protein HMG-17-like 3; high-mobility group protein 17-like 3; high-mobility group (nonhistone chromosomal) protein 17-like 3;
HMGB4
high mobility group box 4
HMGB4; high mobility group box 4; high mobility group protein B4; FLJ40388; HMG2 like; dJ1007G16.5;
HDX
highly divergent homeobox
HDX; highly divergent homeobox; chromosome X open reading frame 43 , CXorf43; FLJ30678; CXorf43; D030011N01Rik; MGC126769; MGC126771; OTTHUMP00000062139;
KLC2
kinesin light chain 2
KLC2; kinesin light chain 2; FLJ12387; KLC 2; KLC2_HUMAN; OTTHUMP00000165216; OTTHUMP00000165218; OTTHUMP00000165219; OTTHUMP00000165220;
KLC3
kinesin light chain 3
KLC3; kinesin light chain 3; KLC2L; KLCt; KNS2B; Kinesin light chain 2; KLC2; KLC2 like; KLC2-like; KLC3_HUMAN;
KLC4
kinesin light chain 4
KLC4; kinesin light chain 4; kinesin like 8 , KNSL8; bA387M24.3; kinesin like 8; Kinesin like protein 8; Kinesin-like protein 8; KLC 4; KLC4_HUMAN; KnsI8; KNSL8; kinesin-like 8;
MAP1LC3C
microtubule-associated protein 1 light chain 3 gamma
MAP1LC3C; microtubule-associated protein 1 light chain 3 gamma; microtubule-associated proteins 1A/1B light chain 3C; ATG8J; Autophagy related protein LC3 C; Autophagy related ubiquitin like modifier LC3 C; LC3 like protein 2; MAP1 light chain 3 like protein 2; MAP1 light chain 3 like protein 3; MAP1A/MAP1B LC3 C; Microtubule associated protein 1 light chain 3 gamma; Microtubule associated proteins 1A/1B light chain 3C; LC3-like protein 2; MAP1A/MAP1B light chain 3 C; autophagy-related protein LC3 C; MAP1 light chain 3-like protein 2; MAP1 light chain 3-like protein 3; autophagy-related ubiquitin-like modifier LC3 C; LC3C;
NFKBIL1
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1
NFKBIL1; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1; IKBL; LST1; NFKBIL; NF-kappa-B inhibitor-like protein 1; ikappaBL; I-kappa-B-like protein; inhibitor of kappa B-like protein;
MYL10
myosin, light chain 10, regulatory
MYL10; myosin, light chain 10, regulatory; myosin regulatory light chain 10; MGC3479; MYLC2PL; PLRLC; likely ortholog of mouse myosin light chain 2, precursor; Myosin light chain 2, lymphocyte specific; myosin light chain 2, precursor lymphocyte specific; Precursor lymphocyte specific regulatory light chain; myosin light chain 2, lymphocyte-specific; myosin light chain 2, precursor lymphocyte-specific; precursor lymphocyte-specific regulatory light chain;
MYLK4
myosin light chain kinase family, member 4
MYLK4; myosin light chain kinase family, member 4; myosin light chain kinase family member 4; caMLCK like; SgK085; sugen kinase 85;
HMGN5
high mobility group nucleosome binding domain 5
HMGN5; high mobility group nucleosome binding domain 5; high mobility group nucleosome binding domain 5 , NSBP1, nucleosomal binding protein 1; high mobility group nucleosome-binding domain-containing protein 5; NSBP 1; Nucleosomal binding protein 1; Nucleosome binding protein 1; nucleosome-binding protein 1; high-mobility group nucleosome binding domain 5; NSBP1; NBP-45;
SLC7A6
solute carrier family 7 (amino acid transporter light chain, y+L system), member 6
SLC7A6; solute carrier family 7 (amino acid transporter light chain, y+L system), member 6; Y+L amino acid transporter 2; KIAA0245; LAT 2; LAT3; y+LAT 2; DKFZp686K15246; AI643885; Cationic amino acid transporter y+ system; Solute carrier family 7 (cationic amino acid transporter y+ system) member 6; Solute carrier family 7 member 6; y(+)L type amino acid transporter 2; Y+LAT2; amino acid permease; y(+)L-type amino acid transporter 2; cationic amino acid transporter, y+ system; solute carrier family 7 (cationic amino acid transporter, y+ system), member 6; LAT-2; y+LAT-2;
TLX1NB
TLX1 neighbor
TLX1NB; TLX1 neighbor; putative TLX1 neighbor protein; APT B7; TD1; TDI; TLX1; TLX1 divergent gene protein; TLXNB_HUMAN; Putative protein TDI; APT-B7;
TJAP1
tight junction associated protein 1 (peripheral)
TJAP1; tight junction associated protein 1 (peripheral); tight junction protein 4 (peripheral) , TJP4; tight junction-associated protein 1; PILT; tight junction protein 4 (peripheral); protein incorporated later into tight junctions; TJP4; DKFZp686F06131;
TJP2
tight junction protein 2 (zona occludens 2)
TJP2; tight junction protein 2 (zona occludens 2); deafness, autosomal dominant 51 , DFNA51; tight junction protein ZO-2; Friedreich ataxia region gene X104 (tight junction protein ZO 2); X104; ZO 2; ZO2; zonula occludens protein 2; Friedreich ataxia regi;
TWISTNB
TWIST neighbor
TWISTNB; TWIST neighbor; DNA-directed RNA polymerase I subunit RPA43; twist neighbor protein;
TJP3
tight junction protein 3 (zona occludens 3)
TJP3; tight junction protein 3 (zona occludens 3); tight junction protein ZO-3; ZO 3; zona occludens protein 3; zonula occludens protein 3; ZO3; ZO-3; MGC119546;
VTI1A
vesicle transport through interaction with t-SNAREs homolog 1A (yeast)
VTI1A; vesicle transport through interaction with t-SNAREs homolog 1A (yeast); vesicle transport through interaction with t-SNAREs homolog 1A; MVti1; Vti1 rp2; SNARE Vti1a beta protein; Vesicle transport through interaction with tSNAREs homolog 1A (yeast); SNARE Vti1a-beta protein; vesicle transport v-SNARE protein Vti1-like 2; VTI1RP2; Vti1-rp2;
VTI1B
vesicle transport through interaction with t-SNAREs homolog 1B (yeast)
VTI1B; vesicle transport through interaction with t-SNAREs homolog 1B (yeast); vesicle transport through interaction with t-SNAREs homolog 1B; VTI2; HGNC:17793; V SNARE; Vesicle associated soluble NSF attachment protein receptor; Vesicle transport through interaction with t SNAREs 1B; Vesicle transport through interaction with t SNAREs homolog 1B (yeast); Vesicle transport v-SNARE protein Vti1-like 1; VTI1; VTI1 like; Vti1 rp1; Vti1-rp1; VTI1B_HUMAN; VTI1L; VTI1L1; vesicle-associated soluble NSF attachment protein receptor; v-SNARE; VTI1-LIKE;
VANGL1
vang-like 1 (van gogh, Drosophila)
VANGL1; vang-like 1 (van gogh, Drosophila); vang (van gogh, Drosophila) like 1, vang, van gogh like 1 (Drosophila); vang-like protein 1; STB2; Loop tail protein 2 homolog; LPP2; MGC5338; STBM2; Strabismus 2; Van Gogh like protein 1; Vang like 1 (van gogh, Drosophila); Vang like protein 1; VANGL 1; OTTHUMP00000013750; OTTHUMP00000013751; OTTHUMP00000013752; van Gogh-like protein 1; loop-tail protein 2 homolog; KAI1 C-terminal interacting tetraspanin; KITENIN;
CDLC2
Cytoplasmic dynein light chain 2
CDLC2; Cytoplasmic dynein light chain 2; CG5450 gene product from transcript CG5450-RA; C87222; cytoplasmic; DNCL1B; MGC17810; 8 kDa dynein light chain b; Dlc2; DLC8b; DYL2_HUMAN; Dynein light chain 2; Dynein light chain 2, cytoplasmic; Dynein light chain LC8 type 2; Dynein light chain LC8-type 2; Dynll2; MGC72334; cytoplasmic dynein light chain 2, isoform A; CG5450-PA; Cdlc2-PA; 8kd dynein light chain; dynein; cyto dynein light chain 2; cytoplasmic dynein; cytoplasmic dynein light chain 2, isoform B; CG5450-PB; Cdlc2-PB; anon-WO0140519.117; Cdcl2; CG5450; dlc; Dmel\CG5450;
TOX3
TOX high mobility group box family member 3
TOX3; TOX high mobility group box family member 3; TNRC9, trinucleotide repeat containing 9; CAGF9; trinucleotide repeat containing 9; trinucleotide repeat-containing gene 9 protein; CAG trinucleotide repeat-containing gene F9 protein; TNRC9;
HDL
High-Density Lipoprotein
high density lipoprotein; APOA1; APOA2; APOC1; Apolipoprotein A C I; Apolipoprotein A I; Apolipoprotein A II; High-density lipoprotein; HDL; Human HDL;
COMMD3-BMI1
COMMD3-BMI1 readthrough
COMMD3-BMI1;COMMD3-BMI1 readthrough;chromosome: 10;DKFZp434I153;COMMD3-BMI1 read-through protein;COMMD3-BMI1 read-through protein;
Fcamr
Fc receptor, IgA, IgM, high affinity
FCAMR;Fc receptor, IgA, IgM, high affinity;ENSMUSG00000026415;1;1 F;MGC129330, MGC129331;high affinity immunoglobulin alpha and immunoglobulin mu Fc receptor;high affinity immunoglobulin alpha and immunoglobulin mu Fc receptor;mFcamR;Fca/m receptor;Fc IgA/IgM receptor;fc alpha/mu receptor;
HMGN2
high mobility group nucleosomal binding domain 2
HMGN2;high mobility group nucleosomal binding domain 2;4986;ENSG00000198830;HMG17;1p36.1;MGC5629, MGC88718;non-histone chromosomal protein HMG-17;non-histone chromosomal protein HMG-17;high mobility group protein N2;nonhistone chromosomal protein HMG-17;high-mobility group nucleosomal binding domain 2;high-mobility group (nonhistone chromosomal) protein 17;high mobility group nucleosome-binding domain-containing protein 2;
NFKBID
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta [ Homo sapiens
NFKBID;nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta;15671;ENSG00000167604;TA-NFKBH;IkappaBNS;19q13.12;MGC11314, MGC149503;NF-kappa-B inhibitor delta;NF-kappa-B inhibitor delta;ikB-delta;ikappaBdelta;I-kappa-B-delta;T-cell activation NFKB-like protein;
NME1-NME2
NME1-NME2 readthrough
NME1-NME2;NME1-NME2 readthrough;33531;ENSG00000011052;NMELV;NM23-LV;17q21.3;FLJ93990;NME1-NME2 protein;NME1-NME2 protein;NME1-NME2 readthrough transcript;EC 2.7.4.6;
PRHOXNB
parahox cluster neighbor
PRHOXNB;parahox cluster neighbor;17785;ENSG00000183463;URAD;13q12.2;putative 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase;putative 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase;parahox neighbor;OHCU decarboxylase;EC 4.1.1.n1;
SLC7A10
solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10 [ Homo
SLC7A10;solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10;11058;ENSG00000130876;asc-1;HASC-1;19q13.1;FLJ20839;asc-type amino acid transporter 1;asc-type amino acid transporter 1;solute carrier family 7 member 10;solute carrier family 7, (neutral amino acid transporter, y+ system) member 10;solute carrier family 7, (cationic amino acid transporter, y+ system) member 10;
Slc7a9
solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system),
SLC7A9;solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9;ENSRNOG00000012344;1q21;MGC114282;B(0,+)-type amino acid transporter 1;B(0,+)-type amino acid transporter 1;b(0,+)AT;solute carrier family 7 member 9;glycoprotein-associated amino acid transporter b0,+AT1;solute carrier family 7 (cationic amino acid transporter, y+ system), member 9;
D10Bwg1379e
DNA segment, Chr 10, Brigham & Womens Genetics 1379 expressed
Arfgef3; mKIAA1244; 9630004D11; B930094H20Rik;
D4Bwg0951e
DNA segment, Chr 4, Brigham & Womens Genetics 0951 expressed
Lurap1l; AV077978; AV175137; WI-13707; bM350F23.1; 1110029A09Rik; RP24-318C20.1;
Dnal1
DNAL1 dynein, axonemal, light chain 1 [ Homo sapiens ]
axonemal; Axonemal dynein light chain 1; Axonemal dynein light chain; C14orf168; Chromosome 14 open reading frame 168; CILD16; DNAL 1; dnal1; DNAL1_HUMAN; Dynein axonemal light chain 1; Dynein light chain 1; Dynein light chain 1 axonemal; MGC12435;
GGTLC1
GGTLC1 gamma-glutamyltransferase light chain 1 [ Homo sapiens ]
gamma-glutamyltransferase light chain 1; 16437; Ensembl:ENSG00000149435; MGC50550; gamma-glutamyl transpeptidase; gamma-glutamyltransferase-like protein 6; gamma-glutamyltransferase-like activity 3; gamma-glutamyltransferase-like activity 4; 2.3.2.2; GGTL6; GGTLA3; GGTLA4; dJ831C21.1; dJ831C21.2;
High-Throughput Screening
Creative BioMart offers a unique combination of target class and cell biology expertise to provide services tailored to your requirements. Our platforms offer high-throughput screening and high-content profiling using standard cell models, human primary cells or disease-related cell lines. Based ...
High-throughput Protein Production
Creative BioMart's professional team can help accelerate your project by providing high-throughput protein production services of up to 1,000 variants within 30 working days. We provide one-stop high-throughput protein production services, including gene synthesis, mutagenesis, subcloning, pilot-sca...
High Yield Protein Production
As one of the world's leading suppliers of protein services, Creative BioMart provides personalized services to drive yield improvements in protein production. Our expert team is able to greatly increase the cell density within the bioreactor to achieve elevated productivity. Our ultrahigh yields al...
High Concentration Formulation (HCF) Technology
Development of formulations for protein drugs requiring high dosing may become challenging for solubility limited proteins and for 1.5 mL allowable administration volume that requires 100 mg/mL protein concentrations. The optimization of formulation conditions for highly concentrated biologics neces...
Nature: Fighting Alzheimer's Disease from the Perspective of Immune Transmitter
Nov. is the national Alzheimers disease (AD) Awareness Month for America. And it widely affects old people around the world. It is one of the common forms of dementia. According to some statistics, every seven second, there will be one people suffer AD. In Germany and Switzerland alone, around 1.5...
Two proteins, ATG12 and ATG5 Might Help People Developing Innovative Cancer Therapies
Scientists at The Scripps Research Institute (TSRI) have found two key subunits within a cell that helps maintaining cell health. They identified how the two proteins help create organelles. Their discoveries make people think about interfering with the formation of these organelles and lead to new ...
Novel Method for Detection of Ovarian Cancer Might Launch Soon
Ovarian cancer is considered to be the most difficult to detect in kinds of cancers. It is difficult to note or detect at early cancer stage, if pain occurs, people might treat it as other symptoms as often been mistaken for other diseases. This makes cancer prevention and control very difficult. D...
Antibodies Were Turned into Highly Tuned Nanobodies by New Technology
Antibodies, one of the most useful tools in biology and medicine, play an important role in recognizing and homing in on molecular targets. Nanobodies, the tiny cousins of antibodies, can do the same work. And because of their simplicity, Nanobodies are comparatively easier to produce. Unluckily, bo...
2012 Trends and Highlights in Biology Industry
Whats the most popular in 2012 in biology industry? With the approaching of 2013, here the following we picked ten trends and highlights from the perspective of un-professional, let see them together: 1. Human Origins and Evolution: Several different studies highlight ongoing research on our earl...
Cerecor Acquired COMT Inhibitors and MK-0657 Rights from Merck
On Apr. 19, 2013, Cerecor, a Baltimore-based biotech focused on neuroscience, has picked up two CNS programs from the U.S. drug giant Merck. Cerecor acquired the exclusive global rights to MK-0657, an NR2B antagonist, as well as similar rights to catechol-O-methyltransf...
The Exclusive Right Buyout of Sanofi’s Ophthalmology Antibodies by Regeneron
Sanofi and Regeneron are old partners that have worked together for many times and gained achievements, for example the colon-cancer drug Zaltrap and REGN727. On May 3, 2013, Regeneron Pharmaceuticals announced two preclinical programs for its grow...
The Building of Merck Serono was Bought by A Consortium
On May 22, 2013, it was reported that the former building of drug company Merck Serono in Geneva was bought by the two richest men in Switzerland: Hansjrg Wyss and Ernesto Bertarelli, actually to a consortiumCampus Biotech. Dramatically it is Bertarelli who sold the Serono to Merck in 2007. About...
